Select your location
James has worked across the biopharma industry, mostly with Big Pharma global manufacturers, NGOs and the U.S. Government.
He has supported initiatives for global marketing organizations, established new Ways of Working for cross-functional brand teams and supporting implementation tools, as well as enabled organizational transformation initiatives in R&D, Medical Affairs, Market Access and Marketing.
Our latest thinking
Strategic framework for opioid abatement funds by cities and counties
Opioid abatement funds represent a significant opportunity for communities impacted by the opioid crisis.
Rethinking the future of public health
Now is the time to rethink the future of public health. Recent public health emergencies exposed gaps in state and local public health infrastructure.
How state governments should use opioid settlement funds
With opioid settlement funds now available, the state government opioid epidemic response can address the economic and community health impacts. Read more
How can the pharma value chain be more efficient?
Streamlining the pharmacy value chain offers opportunity to lower costs, preserve value and help patients.
